QNTM vs. SMH
QNTM (Quantum BioPharma Ltd) is a stock, while SMH (VanEck Semiconductor ETF) is Semiconductors fund tracking the MVIS US Listed Semiconductor 25 Index. Over the past 5 years, QNTM returned -52.03%/yr vs 33.46%/yr for SMH. Their 0.15 correlation means their historical movements had little consistent relationship.
Performance
QNTM vs. SMH - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, QNTM achieves a -60.41% return, which is significantly lower than SMH's 50.09% return.
QNTM
- 1D
- 1.76%
- 1M
- -17.66%
- 6M
- -36.90%
- YTD
- -60.41%
- 1Y
- -87.81%
- 3Y*
- -67.70%
- 5Y*
- -52.03%
- 10Y*
- —
- ALL TIME*
- -51.98%
SMH
- 1D
- 0.30%
- 1M
- -8.74%
- 6M
- 33.97%
- YTD
- 50.09%
- 1Y
- 90.95%
- 3Y*
- 50.56%
- 5Y*
- 33.46%
- 10Y*
- 34.16%
- ALL TIME*
- 11.06%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $262.51K | $263.06K | $1.42M | |
| $8.28B | $7.64B | $7.07B |
QNTM vs. SMH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
QNTM Quantum BioPharma Ltd | -60.41% | 98.37% | -93.84% | 16.67% | -22.71% | -34.62% | -71.27% | -87.38% | 145.98% |
SMH VanEck Semiconductor ETF | 50.09% | 49.17% | 39.10% | 73.38% | -33.53% | 42.13% | 55.53% | 64.45% | -19.66% |
Correlation
The correlation between QNTM and SMH is 0.10, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.10 |
Correlation (3Y) Balances recent behavior with more history. | 0.10 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.14 |
Correlation (All Time) Calculated using the full available price history since Jun 8, 2018 | 0.15 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
QNTM vs. SMH — Risk / Return Rank
QNTM
SMH
QNTM vs. SMH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Quantum BioPharma Ltd (QNTM) and VanEck Semiconductor ETF (SMH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| QNTM | SMH | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.89 | ||
| Sortino ratioReturn per unit of downside risk | -3.99 | ||
| Omega ratioGain probability vs. loss probability | 0.87 | 1.36 | -0.49 |
| Calmar ratioReturn relative to maximum drawdown | -0.95 | 3.58 | -4.53 |
| Martin ratioReturn relative to average drawdown | -1.19 | 14.64 | -15.83 |
Loading charts...
Drawdowns
QNTM vs. SMH - Drawdown Comparison
The maximum QNTM drawdown since its inception was -99.98%, which is greater than SMH's maximum drawdown of -84.96%. Use the drawdown chart below to compare losses from any high point for QNTM and SMH.
Loading charts...
Drawdown Indicators
| QNTM | SMH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.98% | -84.96% | -15.02% |
Max Drawdown (1Y)Largest decline over 1 year | -92.81% | -24.62% | -68.19% |
Max Drawdown (3Y)Largest decline over 3 years | -97.98% | -35.74% | -62.24% |
Max Drawdown (5Y)Largest decline over 5 years | -98.42% | -45.30% | -53.12% |
Max Drawdown (10Y)Largest decline over 10 years | — | -45.30% | — |
Current DrawdownCurrent decline from peak | -99.97% | -19.19% | -80.78% |
Average DrawdownAverage peak-to-trough decline | -92.34% | -40.89% | -51.45% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 73.68% | 6.01% | +67.67% |
Volatility
QNTM vs. SMH - Volatility Comparison
Quantum BioPharma Ltd (QNTM) has a higher volatility of 16.50% compared to VanEck Semiconductor ETF (SMH) at 14.70%. This indicates that QNTM's price experiences larger fluctuations and is considered to be riskier than SMH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| QNTM | SMH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 16.50% | 14.70% | +1.80% |
Volatility (6M)Calculated over the trailing 6-month period | 106.32% | 33.13% | +73.19% |
Volatility (1Y)Calculated over the trailing 1-year period | 146.13% | 38.57% | +107.56% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 134.30% | 36.50% | +97.80% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 139.57% | 33.32% | +106.25% |
Dividends
QNTM vs. SMH - Dividend Comparison
QNTM has not paid dividends to shareholders, while SMH's dividend yield for the trailing twelve months is around 0.20%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
QNTM Quantum BioPharma Ltd | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SMH VanEck Semiconductor ETF | 0.20% | 0.31% | 0.44% | 0.60% | 1.18% | 0.51% | 0.69% | 1.50% | 1.88% | 1.43% | 0.80% | 2.14% |
Frequently Asked Questions
QNTM and SMH have a correlation of 0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
QNTM has higher volatility (16.50%) compared to SMH (14.70%). In terms of maximum drawdown, QNTM dropped -99.98% vs SMH's -84.96%.
SMH currently has the higher Sharpe Ratio (2.29 vs -0.60), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for QNTM and SMH
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer